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Sunday, February 8, 2015 65alipid bilayer interactions. To understand Ab-lipid interactions at molecular
level, we have performed all-atom explicit solvent replica exchange molecular
dynamics simulations in the isobaric-isothermal ensemble of the Ab monomer
binding to the zwitterionic DMPC bilayer. Upon binding, Ab undergoes a dra-
matic structural transition from random coil state in water to a state predomi-
nated by stable helical structure in the peptide’s hydrophobic C-terminal and,
to a lesser extent, the central hydrophobic cluster. In addition, binding to the lipid
bilayer induces the formation of the intrapeptide Asp23-Lys28 salt bridge. The
peptide’s C-terminal and central hydrophobic cluster do not only govern binding
to the bilayer but they also penetrate into the bilayer core. In contrast, the polar
N-terminal and turn region remain solvated and mainly form interactions with
the bilayer surface. This partial insertion of Ab reduces the local density of lipids
and creates an indentation in the bilayer. Surprisingly, peptide insertion does not
significantly distort lipid structural properties or enhance water permeation.
Taken together, these results suggest that Ab aggregation in the presence of a
zwitterionic lipid bilayer is likely to be different from that in bulk water. Small
structural perturbations in lipids induced by the Abmonomer may constitute the
molecular basis of its low cytotoxicity.
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Small oligomers of Amyloid-b (Ab), rather than the mature fibrils, are sus-
pected to initiate Alzheimer’s disease (AD). The structures of these oligomers
in the solution, and in the membrane phase, are expected to provide significant
cues for addressing their toxicity. However, it is difficult to determine the struc-
ture of these peptides as they are transient, and only exist at low mM concen-
trations. We recently combined rapid fluorescence techniques with slower
two-dimensional solid state NMR to obtain useful atomic-level information
on their structure in the solution phase1,2. However, though membrane interac-
tion is a necessary step for this extra-cellular peptide to be toxic3, their structure
in the membrane phase remains elusive. We have developed a modified Surface
Enhanced Raman Spectroscopy method which is able to probe the structure of
membrane proteins at individual residue levels. Using this technique, we deter-
mine the region-wise structure of the membrane-active oligomers, and compare
these with those determined by solid state NMR spectroscopy. We show that
there are critical differences in the structure of the oligomers and the fibrils,
even though they share the same gross molecular architecture. These differ-
ences may be the key to understanding.
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The deposition of amyloid b (Ab) peptides is a pathological hallmark of
Alzheimer’s disease. Ab peptides were previously considered to interact specif-
ically with ganglioside-containing membranes. However, several studies have
suggested that Ab peptides also bind to phosphatidylcholine (PC) membranes,
which lead to deformation of membranes and fibrillation of Ab. Moreover, the
role of membrane curvature, one type of deformation produced by binding of
proteins to a membrane, in the binding and fibrillation of Ab remains unclear.
To more clearly understand the relationship between the binding, consequent
membrane deformation and fibrillation of Ab, we examined the amyloid fibril-
lation of Ab (1-40) in the presence of liposomes of various sizes. Membrane
curvature increased with a decrease in the size of the liposomes. We used lipo-
somes made of 1,2-dioleoyl-sn-glycero-3- phosphocholine to eliminate electro-
static effects. The results obtained showed that liposomes of smaller sizes
(% 50 nm) significantly accelerated the nucleation step, thereby shortening
the lag time of fibrillation. On the other hand, liposomes of larger sizes
decreased the amount of fibrils, but did not notably affect the lag time. The mor-
phologies of fibrils, which were monitored by total internal reflection fluores-
cence microscopy, atomic force microscopy, and transmission electronmicroscopy, revealed that the length of Ab (1-40) fibrils became shorter and
the amount of amorphous aggregates became larger as liposomes increased
in size. These results suggest that the curvature of membranes coupled with
an increase in water-accessible hydrophobic regions is important for binding
and concentrating Ab monomers, leading to amyloid nucleation. Furthermore,
amyloid fibrillation on membranes may compete with non-productive binding
to produce amorphous aggregates.
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Ab is 40-residue peptide, unstructured and present in all brain tissue. In Alz-
heimer’s disease, Ab peptides spontaneously aggregate and form fibrils. Fibril
formation begins with a nucleation step that is poorly understood. Factors that
cause nucleation are likely to be related with the cause of Alzheimer’s disease.
To understand the nucleation step, while preventing protein aggregation into
fibrils, we have encapsulated Ab peptides in reverse micelles (RMs) -
nanometer-sized droplets of water, surrounded by a surfactant, immersed in
an organic solvent. In addition to preventing aggregation, RMs may mimic
aspects of the in vivo circumstances where Ab peptides form fibrils, such as
molecular crowding, confinement, and high ionic strength. MD simulations
were performed to better understandRMproperties, and the behavior of Ab pep-
tides in an RM. This computational study provides a detailed molecular model
for an AOTRM.Our results show that 64 AOTmolecules and aWo¼ 7.5 yields
an RMwith dimensions that are consistent with experimental data. WhenWo¼
7.5 and the number of AOTmolecules is greater than 64, the RM shape becomes
markedly non-spherical and begins to split. When Wo ¼ 7.5 and the number of
AOT molecules is less than 64, the resulting RM has an insufficient number of
AOT molecules to separate water from isooctane. Even with 64 AOT per RM,
there is an overlap of water and isooctane phases that facilitates both the escape
ofwaters from theRMcore, and their re-entry. These processes - observable now
in a detailed simulation - account for the narrow size distribution of RM at equi-
librium. When incorporated in an RM, Ab peptides may locate in the surfactant
layer and increase RM surface area as well as volume.
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Alzheimer’s disease (AD) is a fatal neurodegenerative disorder that is the most
common cause of dementia. The self-assembly of the b-amyloid peptide (Ab)
into ordered aggregates, including oligomers and fibrils, is a major hallmark of
AD. As we age, significant alterations in our cellular structure, with implica-
tions for cellular mechanics, occur. An example of such changes are alterations
in the structure of microtubules within cells. As aging is the largest risk factor
for the development of AD, we investigated the role of microtubule structure on
a cell’s ability to cope with exposure to Ab. Microtubules in GT1-7 cells were
systematically altered using a variety of microtubule-altering drugs. Nocoda-
zole and cholchicine were used to disrupt microtubules; paclitaxel was used
to stabilize microtubules. The effectiveness of the drugs to change microtubule
structure was confirmed by fluorescence microscopy and mechanical measure-
ments using an atomic force microscope. Control cells and cells with altered
microtubule structure were then exposed to monomeric and oligomeric solu-
tions of Ab, as confirmed by several assays. Next, we determined the extent
of Ab binding to cells using flow cytometry, cell death using a variety of
toxicity assays, and Ab-induced changes in cell mechanical properties. We
found that altering microtubule structure had little effect on the ability of Ab
to bind cells. However, Ab-related toxicity was enhanced when cells had dis-
rupted microtubule networks, indicating that they were more sensitive to expo-
sure to Ab. Cells that had their microtubule networks chemically stabilized
were more resistant to Ab-related toxicity.
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Protein aggregation is a complex, multistep process, but the first step is likely the
formation of a dimer through non-specific interactions of two disordered mono-
mers. In this work we measure the rate of reconfiguration, or intramolecular
diffusion, of monomeric Abeta peptides and find a correlation between this
rate and the aggregation rate. Using the method of Trp-Cys contact quenching
we find that the rate of reconfiguration is ~5 times faster for Abeta40, which
66a Sunday, February 8, 2015aggregates slowly, than forAbeta42, which aggregates quickly. Furthermore, the
rate of reconfiguration for Abeta42 speeds up at higher pH, which slows aggre-
gation, and in the presence of the aggregation inhibitor curcumin. These results
are commensurate with a model of the first step of aggregation, described here,
that is a kinetic competition between reconfiguration and bimolecular diffusion.
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Alzheimer’s disease (AD), the most common form of dementia, is characterized
by extracellular plaques in the brain created when monomeric amyloid-b (Ab)
protein aggregates into fibrillar structures. Soluble Ab aggregates, including
oligomers that form along the reaction pathway, are believed to be themore toxic
species and can increase the production of reactive oxygen species (ROS). Poly-
phenols have been suggested as a complimentary AD therapeutic based on
epidemiological evidence that polyphenol-rich diets correlate with a reduced
incidence of AD. In particular, many flavonoids, a subclass of polyphenols,
have the ability to inhibit Ab aggregation. Alternatively, polyphenols can
counter Ab-induced cellular responses by neutralizing ROS through their anti-
oxidant properties. This study sought to identify polyphenols that can reduce
Ab-induced apoptosis by inhibiting Ab aggregation and/or reducing ROS.
Polyphenols investigated include quercetin (QUE), rhamnetin (RHA), isorham-
netin (IRHA), and tamarixetin (TAM). Using SDS-PAGE and Western blot to
evaluate oligomer size, only IRHA was unable to reduce Ab oligomers 250 –
100 kDa in size, while QUE reduced these oligomers by 88.35 2.4%. All com-
pounds reduced Ab oligomers <100 kDa in size, although IRHA was still the
weakest inhibitor. Antioxidant capabilities were quantified in vitro relative to
Trolox, a vitamin E analog. All compounds tested exhibited antioxidant capa-
bility similar to Trolox. To assess the effect of anti-aggregation and antioxidant
properties on Ab-induced apoptosis, human neuroblastoma cells were stained
using TUNEL, which identifies breaks in the DNA strand. Polyphenols with
anti-aggregation properties successfully reduced apoptosis, and it is hypothe-
sized that antioxidant activity will also have a protective effect.
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The aggregation and deposition of the polypeptide Amyloid-b (Ab) in the brain
is implicated in the pathology of Alzheimer disease (AD). It has been known
that soluble oligomeric forms of Ab are the primary neurotoxic agents in
AD, rather than insoluble fibrils. This has resulted in a plethora of research
investigating the cellular mechanism of Ab oligomer toxicity. However, how
these toxic oligomers proliferate throughout the AD brain remains elusive.
Emerging evidence implicates that a prion-like mechanism of propagation
may cause the widespread proliferation of toxic Ab oligomers in AD. We
have observed that a specific oligomeric form of Ab, called large fatty acid-
derived oligomers (LFAOs), undergo self-propagative replication in a
template-assisted manner, resulting in the formation of quantitatively more
LFAOs. The current research investigates the experimental parameters govern-
ing the efficiency of LFAO replication by self-propagation, and shows that
LFAOs specifically activate NF-kB in human neuroblastoma cells. Further-
more, structural characteristics of propagated LFAOs have been evaluated to
assess the fidelity of the LFAO self-propagative replication process. This study
is the first detailed investigation into the mechanisms governing self-
propagating Ab oligomers in vitro, revealing novel insight into the potential
proliferation mechanism of toxic Ab aggregates in AD.
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The aggregation of amyloid-beta (Ab) peptides plays a crucial role in the eti-
ology of Alzheimer’s disease (AD). Recently, it has been reported that an
A2T mutation in Ab can protect from AD. Interestingly, a non-polar A2V mu-
tation has been also found to offer protection against AD in the heterozygous
state, while causing early-onset AD in homozygous carriers. Since the confor-
mational landscape of the Ab monomer is known to directly contribute to theearly-stage aggregation mechanism, it is important to characterize the effect
of the A2T and A2V mutations on the Ab1-42 monomer structure. Here, we
have performed extensive atomistic replica exchange molecular dynamics sim-
ulations of the solvated wild-type (WT), A2V, and A2T Ab1-42 monomers.
Our simulations reveal that, although all three variants remain as a collapsed
coil in solution, there exist significant structural differences among them at
shorter timescale. An enhanced double hairpin population in A2V is noticed
compared to WT, similar to those reported in the toxic WT Ab1-42 oligomers.
Hydrophobic clustering between the N-terminus and the central and C-terminal
hydrophobic patches promotes such double hairpin formation in A2V. In
contrast, the A2T mutation engages the N-terminus in unusual electrostatic in-
teractions with distant residues, such as K16 and E22, resulting in ‘‘unique’’
population comprising only the C-terminal hairpin. These findings imply that
a single A2X (X¼V/T) mutation in the primarily disordered N-terminus of
Ab1-42 monomer can dramatically alter the b-hairpin population and switch
the equilibrium toward alternative structures. The atomistically detailed,
comparative view of the structural landscapes of A2V and A2T variant mono-
mers obtained in this study can help understanding the mechanistic differences
in their early-stage aggregation.
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Alzheimer’s disease (AD) is a costly and devastating illness, which is charac-
terized by progressive neurological degeneration, manifesting in memory and
cognitive impairment until eventual death. Although the exact mechanism
for AD is unknown, it is hypothesized that disease etiology lies within the
aggregation of the protein amyloid-b (Ab), whose aggregates are toxic to
neuronal cells. Thus, inhibition of Ab aggregation is one therapeutic strategy.
Peptoids are peptide derivatives that resist proteolytic degradation through a
structural modification in the backbone, while maintaining side chain chemis-
try. This study examines the therapeutic potential of three peptoids designed to
mimic the hydrophobic core of Ab and incorporate a neutral, positive, or nega-
tive spacer between aromatic side chains. These peptoids are assessed for their
ability to abate Ab aggregation and reduce the aggregate-induced NF-kB acti-
vation in neuronal cells.
To examine the effect of peptoids on small, oligomeric aggregate formation,
Ab monomer was solubilized in DMSO and diluted into PBS to initiate olig-
omer formation. Oligomer size was assessed via SDS-PAGE and Western
blot; oligomer structure was evaluated using ANS. Finally, the effect of pep-
toids on Ab physiological activity was assessed using activation of NF-kB in
human neuroblastoma cells.
All three peptoids reduced the quantity and size of oligomers formed, with the
peptoid containing the positively charged spacer possessing the greatest inhib-
itory capabilities. In contrast, only peptoids containing a neutral or negatively
charged spacer also altered oligomer structure. NF-kB activation was signif-
icantly reduced for oligomers formed in the presence of all three peptoids.
In addition, when peptoid was added post-oligomerization, peptoids with a
neutral and negatively charged spacer both elicited a significant reduction
in NF-kB activation. In sum, peptoids are capable of inhibiting Ab oligomer-
ization and associated physiological activity, demonstrating potential as AD
therapeutics.
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Amyloid deposits are implicated in the pathogenesis of many neurodegenera-
tive diseases such asAlzheimer’s disease (AD). The inhibition of b-sheet for-
mation has been considered as the primary therapeutic strategy for the AD.
In this presentation, I will present our recent results of the influences of
different carbon nanoparticles (CNPs) (including graphene oxides, pristine
single-walled carbon nanotubes–SWCNTs, hydroxylated SWCNTs, fullerenes
including C60 and C180) on the aggregation of Ab(16-22) and full-length Ab
peptides. Our replica exchange molecular dynamics (REMD) simulations
show that CNPs shift the conformations of Ab oligomers from ordered
b-sheet-rich structures toward disordered coil aggregates. Atomic force micro-
scopy (AFM) experiments further confirm the inhibitory effect of CNPs on Ab
